Planned Vaginal Delivery vs Planned Cesarean Delivery in Preterm Twins
NCT ID: NCT04232436
Last Updated: 2020-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
204 participants
OBSERVATIONAL
2019-07-01
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The optimal mode of delivery for preterm twins remains controversial. The latest recommendations for clinical practice emphasize that it is not appropriate to recommend one mode of delivery rather than another in the case of twin pregnancies at any term.
In view of all these elements, we wished to carry out a retrospective study at the Montpellier University Hospital in order to compare the neonatal outcome of preterms twins according to their mode of delivery : planned vaginal delivery versus planned cesarean delivery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preterm Delivery Prevention in Twins With Progesterone
NCT01927029
National Prospective and Comparative Study on the Mode of Delivery of Twins
NCT01987063
Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth
NCT02350231
Natural Progesterone and Preterm Birth in Twins
NCT00480402
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
NCT00141908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Planned vaginal delivery
Planned vaginal delivery
Survival at discharge
Survival at discharge
Survival without severe morbidity
Survival without severe morbidity (IVH, severe BPD, NEC, ROP)
Planned cesarean delivery
Planned cesarean delivery
Survival at discharge
Survival at discharge
Survival without severe morbidity
Survival without severe morbidity (IVH, severe BPD, NEC, ROP)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survival at discharge
Survival at discharge
Survival without severe morbidity
Survival without severe morbidity (IVH, severe BPD, NEC, ROP)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between 24SA and 32SA+6
* January 2010 to July 2019
* The mothers must have gone into labour spontaneously or after preterm rupture of membranes
* first twin in cephalic presentation
Exclusion Criteria
* monoamniotic pregnancies
* cause of delivery other than preterm labor or preterm rupture of membranes
* lethal malformation
* first twin in breech or transverse presentation
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florent FUCHS, PU-PH
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL20_0035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.